Special Offer on Multiple Purchases

Many of our customers purchase more than one product. To cut the cost of multiple purchases we have developed the discount table below which is valid for use until June 2013. Just quote ‘BULK 2013’ on your order to qualify.

Number of Products	Discount Applied
1	List Price
2-4	5%
5-7	7.5%
8-10	10%
10+	Enquire

If you have any queries, please do not hesitate to contact us, +44 (0) 1280 827460, office@caltagmedsystems.co.uk

New Flurochrome for Violet Laser

OC515 The Violet Laser has become a standard component of flow cytometers and is often used for standard markers in multicolour staining panels. Cytognos offers a new flurochrome for this laser which provides maximum resolution of antigenic determinants when used in a multicolour panel. OC515 narrow emission peak results in little spectral overlap requiring minimal intra-laser compensation.

Orange Cytognos 515 (OC515) is a dye with similar spectral properties to Pacific Orange which emits at 515 nm and is characterised by:

- Narrow and well separated emission profiles.

- Optimal relative staining index which reflects high brightness differences between positive and negative populations.

- No excitation is detected in the 488nm laser which reduces compensation requirements.

- Minimal intra-laser compensation requirements.

- Compatible with the standard filter sets of cytometers equipped with violet lasers.

Cytognos Antibodies conjugated with OC515:

CD45-OC515
Product Code: CYT-1380C
Clone: GA90
Format: 0.5ml/100 test
Price: £303

CD138-OC515
Product Code: CYT-1380C
Clone: B-A38
Format: 0.5ml/100 test
Price: £653

                   

Cytognos products are available in the UK exclusively through Caltag Medsystems. See the full range of Cytognos’ products here.

Rare Antibiotics and Bioactive, Natural Compounds Available

A new product range of unique and rare antibiotics and bioactive, natural compounds is now available from Caltag Medsystems.

Bioviotica focus on the discovery and fermentation of rare, biological, active, natural products from bacteria and fungus. These bioactive compounds have proved to be significant tools in medicinal, pharmacological and biochemical research, and in the development of new drugs for the treatment of bacterial and viral infections, cancer and other diseases.

Natural Products are active against bacteria, fungi, or viruses, where they inhibit or modulate enzymes. Today, more than 50% of authorised drugs are Natural Products or derived from Natural Products.

Listed below are the details of the current most popular products. To view Bioviotica’s whole product portfolio please click here.

Mycotoxin TargoSet
Product Code: BVT-L002-1
Price: £1490

The Mycotoxin TargoSet offers a panel of well-characterized and highly pure compounds for screening experiments, cell-based research or as standard compounds. It contains 19 different compounds, all 1mg in size.

Betulin Derivatives TargoSet
Product Code:  BVT-L001-1
Price: £690

The birch tree has been known for a long time for its healing properties in folk medicine. It can be expected that Betulin, an active principle of the birch tree could be used for the treatment of various pathologies. Betulin can be rapidly converted to its ‘more’ active derivatives, with a wide spectrum of biological and pharmacological activities such as: anti-inflammatory, antimalarial, anti-HIV and antineoplasic. This set contains 13 different compounds, all 3mg in size.

For further information on Bioviotica and their products please click here.

BioViotica products are available in the UK exclusively through Caltag Medsystems. Please do not hesitate to contact us, +44 (0) 1280 827460, office@caltagmedsystems.co.uk if you have any questions. If you are interested in purchasing more than one product, then please take advantage of our current offer.

Tasty Treats

Here at Caltag Medsystems, we like to go the extra mile to look after our customers, and, as a little thank you for orders received we’re sending out bags of assorted biscuits with each purchase.  Just for you.

Get 5 of your colleagues to follow us on twitter and we’ll send a larger goody bag. Why not share them with your colleagues? Find us @caltagmedsystem

The promise of stem cells: What one childs success might mean for the future of cell-based therapies.

DNA was in the spotlight last month with the 60^th anniversary of Watson and Crick’s publication describing the double helix shape of DNA (on April 25) and the re-release of Jurassic Park in stunning 3-D. While the latter was merely Hollywood’s dramatic, yet highly entertaining spin on some rather questionable scientific practices, it was emphasized several times during the course of the movie that DNA was the true star (sorry T-Rex).

From novel drug discoveries to 3-D printers building synthetic tissues,  it’s amazing how advanced our scientific knowledge and technology have become in such a relatively short period of time since Watson and Crick published their paper. Earlier this week, a story emerged about Hannah Warren, a 2-year-old girl that underwent a lifesaving operation to receive a synthetic trachea transplant bioengineered from her own stem cells. While this wasn’t the first report of a successful transplant of this kind, it was the first time the technique was used on a child.

The synthetic trachea was created using stem cells from Hannah’s bone marrow which were cultured on a tube-shaped scaffold made out of plastic fibers. Following the operation, doctors reported that the child was recovering well, despite a few complications related to the surgery. Transplants such as these have a better success rate when the patient’s own stem cells are used, although further research is needed to fully understand what happens to the grafts over time.

A recent study reported that nearly two thirds of children that received stem cell transplants returned to the hospital with complications within six months. The technique for the synthetic windpipe transplant is not yet FDA approved, but this particular case for Hannah was authorized because there was little hope for her survival otherwise.

The possibilities for cell-based therapies using human stem cells are seemingly endless, especially when positive stories, such as Hannah’s, offer the public insight into this emerging technology. Treatment of numerous diseases may be possible with the use of stem cells directed to differentiate into specific cell types. Before that can happen though, much more research is needed to overcome significant technical barriers. In the meantime, we’ll rely on more reports of promising research and future Hollywood blockbusters to keep the excitement of important scientific advancements alive.

Caltag Medsystems is the exclusive distributor for Sciencell products in the UK. For further information on the Sciencell product range please visit http://www.sciencellonline.com/ or contact Caltag Medsystems by email. All UK prices can be found at www.caltagmedsystems.co.uk.

Mysterious Mind-Boggler

Can you solve this mind-boggler?

Email us the correct answer along with your full delivery address and you will receive a complimentary treat!

We have scales A and B balanced perfectly, now all you have to do is figure out how many squares you will need to balance scale C?!

Email your answers to office@caltagmedsystems.co.uk (hints can be provided!)

Market Research

Here at Caltag Medsystems we are working hard on presenting relevant and current information to UK life scientists.

Towards this goal, we are exploring the use of social media, and we would like to know if you think this could be a useful information channel when sourcing reagents.

If you wouldn’t mind sparing 30 seconds to answer a very small survey, we would really appreciate this.

As a little ‘Thank You’, all entries will be entered into a prize draw. Three winners will each receive a £50 Amazon Voucher.

Please click here to access the questions.